or
forgot password

    • cancer clinical trials in maine

    • APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Hematology-Medical Oncology Associates at Central Maine Comprehensive Cancer Center
    Lewiston, Maine 04240
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Scarborough, Maine 04074
    Small Cell Lung Cancer
    Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
    Central Maine Comprehensive Cancer Center at Central Maine Medical Center
    Lewiston, Maine 04240
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Metastatic Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Eastern Maine Medical Center

    Trial Locations
    Eastern Maine Medical Center
    Maine Children's Cancer Program
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
    Maine Children's Cancer Program
    Scarborough, Maine 04074-9308
    Adrenocortical Carcinoma, Localized Resectable Neuroblastoma, Precancerous Condition
    Assessment and Tracking of Long-term Alefacept Safety
    Eileen Ringel
    Waterville, Maine 04901
    Psoriasis
    Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Maine Medical Center - Bramhall Campus
    Portland, Maine 04102
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
    CancerCare of Maine at Eastern Maine Medical Center
    Bangor, Maine 04401
    Lung Cancer
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    CancerCare of Maine at Eastern Maine Medical Center

    Trial Locations
    CancerCare of Maine at Eastern Maine Medical Center
    Maine Children's Cancer Program at Barbara Bush Children's Hospital
    Leukemia
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Maine Center for Cancer Medicine and Blood Disorders
    Scarborough, Maine 04074
    Small Cell Lung Cancer
    Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
    GSK Investigational Site
    Scarborough, Maine 04074
    Neoplasms, Breast
    A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
    Research Site
    Bangor, Maine
    Bladder Cancer, Transitional Cell Bladder Cancer, Urethra Cancer, Ureter Cancer, Renal Pelvis Cancer
    Bone Mineral Density in Postmenopausal Women at Increased Risk of Developing Breast Cancer And Who Are Receiving Exemestane on Clinical Trial CAN-NCIC-MAP3
    Maine Center for Cancer Medicine and Blood Disorders
    Scarborough, Maine 04074
    Breast Cancer, Osteoporosis
    Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    CancerCare of Maine at Eastern Maine Medical Center
    Bangor, Maine 04401
    Leukemia
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Maine Children's Cancer Program at Barbara Bush Children's Hospital
    Scarborough, Maine 04074-9308
    Sarcoma
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Maine Medical Center - Bramhall Campus
    Portland, Maine 04102
    Endometrial Cancer
    Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
    Maine General Medical Center Harold Alfond Center for Cancer Care
    Waterville, Maine 04901
    Acute Myeloid Leukemia
    ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
    Maine Medical Center
    Portland, Maine 04102
    Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    CancerCare of Maine at Eastern Maine Medical Center
    Bangor, Maine 04401
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    A Study for Patients With Small-Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Scarborough, Maine 04074
    Small Cell Lung Cancer
    A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
    Investigational Site
    Scarborough, Maine 04074
    Metastatic Breast Cancer
    AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Maine Medical Center-Bramhall Campus
    Portland, Maine 04102
    Endometrial Cancer
    Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Harold Alfond Center for Cancer Care

    Trial Locations
    Harold Alfond Center for Cancer Care
    Eastern Maine Medical Center
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Erlotinib Hydrochloride and Cabozantinib Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
    York Hospital
    York, Maine 03909
    Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
    Eastern Maine Medical Center Research Center SC
    Bangor, Maine 04401
    Metastatic or Unresectable Cutaneous Melanoma